{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:50:21Z","timestamp":1793829021737,"version":"4.6.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T00:00:00Z","timestamp":1505779200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T00:00:00Z","timestamp":1505779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP 16k07023"],"award-info":[{"award-number":["JP 16k07023"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007591","name":"Akiyama Life Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007591","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670180, 8161101575, 81370077, and 81001220"],"award-info":[{"award-number":["81670180, 8161101575, 81370077, and 81001220"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["Z171100001117091"],"award-info":[{"award-number":["Z171100001117091"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s11064-017-2400-z","type":"journal-article","created":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T03:23:32Z","timestamp":1505791412000},"page":"3525-3536","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Yokukansan Reduces Cuprizone-Induced Demyelination in the Corpus Callosum Through Anti-inflammatory Effects on Microglia"],"prefix":"10.1007","volume":"42","author":[{"given":"Taichi","family":"Nomura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Bando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuhide","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigetaka","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,19]]},"reference":[{"key":"2400_CR1","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1172\/JCI21357","volume":"113","author":"DA Hafler","year":"2004","unstructured":"Hafler DA (2004) Multiple sclerosis. J Clin Invest 113:788\u2013794","journal-title":"J Clin Invest"},{"key":"2400_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ene.12798","volume":"22","author":"N Grigoriadis","year":"2015","unstructured":"Grigoriadis N, van Pesch V (2015) A basic overview of multiple sclerosis immunopathology. Eur J Neurol 22:3\u201313","journal-title":"Eur J Neurol"},{"key":"2400_CR3","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1212\/WNL.40.11.1735","volume":"40","author":"SL Hauser","year":"1990","unstructured":"Hauser SL, Doolittle TH, Lincoln R, Brown RH, Dinarello CA (1990) Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurology 40:1735\u20131739","journal-title":"Neurology"},{"key":"2400_CR4","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1093\/brain\/aws012","volume":"135","author":"MT Fischer","year":"2012","unstructured":"Fischer MT, Sharma R, Lim JL, Haider L, Frischer JM, Drexhage J, Mahad D, Bradl M, van Horssen J, Lassmann H (2012) NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury. Brain 135:886\u2013899","journal-title":"Brain"},{"key":"2400_CR5","doi-asserted-by":"publisher","first-page":"S16-21","DOI":"10.1212\/WNL.45.6_Suppl_6.S16","volume":"45","author":"CF Brosnan","year":"1995","unstructured":"Brosnan CF, Cannella B, Battistini L, Raine CS (1995) Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species. Neurology 45:S16-21","journal-title":"Neurology"},{"key":"2400_CR6","doi-asserted-by":"publisher","first-page":"248","DOI":"10.4088\/JCP.v66n0214","volume":"66","author":"K Iwasaki","year":"2005","unstructured":"Iwasaki K, Satoh-Nakagawa T, Maruyama M, Monma Y, Nemoto M, Tomita N, Tanji H, Fujiwara H, Seki T, Fujii M, Arai H, Sasaki H (2005) A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients. J Clin Psychiatry 66:248\u2013252","journal-title":"J Clin Psychiatry"},{"key":"2400_CR7","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.pnpbp.2008.12.008","volume":"33","author":"A Monji","year":"2009","unstructured":"Monji A, Takita M, Samejima T, Takaishi T, Hashimoto K, Matsunaga H, Oda M, Sumida Y, Mizoguchi Y, Kato T, Horikawa H, Kanba S (2009) Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer\u2019s disease. Prog Neuropsychopharmacol Biol Psychiatry 33:308\u2013311","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2400_CR8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00213-014-3645-8","volume":"232","author":"T Miyaoka","year":"2015","unstructured":"Miyaoka T, Furuya M, Horiguchi J, Wake R, Hahioka S, Tohyma M, Mori N, Minabe Y, Iyo M, Ueno S, Ezoe S, Murotani K, Hoshino S, Seno H (2015) Efficacy and safety of yokukansan in treatment-resistant schizophrenia: a randomized, double-blind, placebo-controlled trial (a positive and negative syndrome scale, five-factor analysis). Psychopharmacology 232:155\u2013164","journal-title":"Psychopharmacology"},{"key":"2400_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/ggi.12696","volume":"17","author":"K Furukawa","year":"2017","unstructured":"Furukawa K, Tomita N, Uematsu D, Okahara K, Shimada H, Ikeda M, Matsui T, Kozaki K, Fujii M, Ogawa T, Umegaki H, Urakami K, Nomura H, Kobayashi N, Nakanishi A, Washimi Y, Yonezawa H, Takahashi S, Kubota M, Wakutani Y, Ito D, Sasaki T, Matsubara E, Une K, Ishiki A, Yahagi Y, Shoji M, Sato H, Terayama Y, Kuzuya M, Araki N, Kodama M, Yamaguchi T, Arai H (2017) Randomized double-blind placebo-controlled multicenter trial of Yokukansan for neuropsychiatric symptoms in Alzheimer\u2019s disease. Geriatr Gerontol Int 17:211\u2013218","journal-title":"Geriatr Gerontol Int"},{"key":"2400_CR10","first-page":"1629","volume":"10","author":"CH Yu","year":"2014","unstructured":"Yu CH, Ishii R, Yu SC, Takeda M (2014) Yokukansan and its ingredients as possible treatment options for schizophrenia. Neuropsychiatr Dis Treat 10:1629\u20131634","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2400_CR11","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s12264-016-0055-4","volume":"32","author":"F Su","year":"2016","unstructured":"Su F, Bai F, Zhang Z (2016) Inflammatory cytokines and Alzheimer\u2019s disease: a review from the perspective of genetic polymorphisms. Neurosci Bull 32:469\u2013480","journal-title":"Neurosci Bull"},{"key":"2400_CR12","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0140-6736(01)05625-2","volume":"358","author":"A Cagnin","year":"2001","unstructured":"Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, Jones T, Banati RB (2001) In-vivo measurement of activated microglia in dementia. Lancet 358:461\u2013467","journal-title":"Lancet"},{"key":"2400_CR13","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.2967\/jnumed.109.066647","volume":"50","author":"J Doorduin","year":"2009","unstructured":"Doorduin J, de Vries EF, Willemsen AT, de Groot JC, Dierckx RA, Klein HC (2009) Neuroinflammation in schizophrenia-related psychosis: a PET study. J Nucl Med 50:1801\u20131807","journal-title":"J Nucl Med"},{"key":"2400_CR14","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.biopsych.2008.04.025","volume":"64","author":"BN van Berckel","year":"2008","unstructured":"van Berckel BN, Bossong MG, Boellaard R, Kloet R, Schuitemaker A, Caspers E, Luurtsema G, Windhorst AD, Cahn W, Lammertsma AA, Kahn RS (2008) Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biol Psychiatry 64:820\u2013822","journal-title":"Biol Psychiatry"},{"key":"2400_CR15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.pharmthera.2016.06.018","volume":"166","author":"Y Ikarashi","year":"2016","unstructured":"Ikarashi Y, Mizoguchi K (2016) Neuropharmacological efficacy of the traditional Japanese Kampo medicine yokukansan and its active ingredients. Pharmacol Ther 166:84\u201395","journal-title":"Pharmacol Ther"},{"key":"2400_CR16","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.brainres.2013.11.015","volume":"16","author":"Y Liu","year":"2014","unstructured":"Liu Y, Nakamura T, Toyoshima T, Lu F, Sumitani K, Shinomiya A, Keep RF, Yamamoto T, Tamiya T, Itano T (2014) Ameliorative effects of yokukansan on behavioral deficits in a gerbil model of global cerebral ischemia. Brain Res 16:300\u2013307","journal-title":"Brain Res"},{"key":"2400_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/1742-2094-10-145","volume":"10","author":"M Furuya","year":"2013","unstructured":"Furuya M, Miyaoka T, Tsumori T, Liaury K, Hashioka S, Wake R, Tsuchie K, Fukushima M, Ezoe S, Horiguchi J (2013) Yokukansan promotes hippocampal neurogenesis associated with the suppression of activated microglia in Gunn rat. J Neuroinflammation 10:145","journal-title":"J Neuroinflammation"},{"key":"2400_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fncel.2014.00073","volume":"8","author":"V Gudi","year":"2014","unstructured":"Gudi V, Gingele S, Skripuletz T, Stangel M, Hermann D, Weissert R (2014) Glial response during cuprizone-induced de-and remyelination in the CNS: lessons learned. Front Cell Neurosci 8:1\u201324","journal-title":"Front Cell Neurosci"},{"key":"2400_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1750-3639.2001.tb00385.x","volume":"11","author":"GK Matsushima","year":"2001","unstructured":"Matsushima GK, Morell P (2001) The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 11:107\u2013116","journal-title":"Brain Pathol"},{"key":"2400_CR20","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.4049\/jimmunol.167.5.2964","volume":"167","author":"EJ McMahon","year":"2001","unstructured":"McMahon EJ, Cook DN, Suzuki KM (2001) Absence of macrophage-inflammatory protein-1alpha delays central nervous system demyelination in the presence of an intact blood-brain barrier. J Immunol 167:2964\u20132971","journal-title":"J Immunol"},{"key":"2400_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0022-510X(87)90055-4","volume":"78","author":"DA Bakker","year":"1987","unstructured":"Bakker DA, Ludwin SK (1987) Blood\u2013brain barrier permeability during cuprizone-induced demyelination: implication for the patho-genesis of immune-mediated demyelinating diseases. J Neurol Sci 78:125\u2013137","journal-title":"J Neurol Sci"},{"key":"2400_CR22","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.1523\/JNEUROSCI.21-18-07046.2001","volume":"21","author":"JL Mason","year":"2001","unstructured":"Mason JL, Suzuki K, Chaplin DD, Matsushima GK (2001) Interleukin-1beta promotes repair of the CNS. J Neurosci 21:7046\u20137052","journal-title":"J Neurosci"},{"key":"2400_CR23","doi-asserted-by":"publisher","first-page":"427","DOI":"10.4049\/jimmunol.168.1.427","volume":"168","author":"HA Arnett","year":"2002","unstructured":"Arnett HA, Hellendall RP, Matsushima GK, Suzuki K, Laubach VE, Sherman P, Ting JP (2002) The protective role of nitric oxide in a neurotoxicant-induced demyelinating model. J Immunol 168:427\u2013433","journal-title":"J Immunol"},{"key":"2400_CR24","first-page":"1","volume":"1","author":"M Makinodan","year":"2009","unstructured":"Makinodan M, Yamauchi T, Tatsumi K, Okuda H, Noriyama Y, Sadamatsu M, Kishimoto T, Wanaka A (2009) Yi-Gan San restores behavioral alterations and a decrease of brain glutathione level in a mouse model of schizophrenia. J Brain Dis 1:1\u20136","journal-title":"J Brain Dis"},{"key":"2400_CR25","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/glia.22770","volume":"63","author":"T Tanaka","year":"2015","unstructured":"Tanaka T, Murakami K, Bando Y, Yoshida S (2015) Interferon regulatory factor 7 participates in the M1-like microglial polarization switch. Glia 63:595\u2013610","journal-title":"Glia"},{"key":"2400_CR26","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.neures.2013.01.009","volume":"75","author":"T Nomura","year":"2013","unstructured":"Nomura T, Bando Y, Bochimoto H, Koga D, Watanabe T, Yoshida S (2013) Three-dimensional ultra-structures of myelin and the axons in the spinal cord: application of SEM with the osmium maceration method to the central nervous system in two mouse models. Neurosci Res 75:190\u2013197","journal-title":"Neurosci Res"},{"key":"2400_CR27","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neuint.2015.01.002","volume":"81","author":"Y Bando","year":"2015","unstructured":"Bando Y, Nomura T, Bochimoto H, Murakami K, Tanaka T, Watanabe T, Yoshida S (2015) Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis. Neurochem Int 81:16\u201327","journal-title":"Neurochem Int"},{"key":"2400_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0165-5728(90)90073-V","volume":"27","author":"E Blasi","year":"1990","unstructured":"Blasi E, Barluzzi R, Bocchini V, Mazzolla R, Bistoni F (1990) Immortalization of murine microglial cells by a v-raf\/v-myc carrying retrovirus. J Neuroimmunol 27:229\u2013237","journal-title":"J Neuroimmunol"},{"key":"2400_CR29","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.phymed.2014.06.004","volume":"21","author":"Y Nakatani","year":"2014","unstructured":"Nakatani Y, Tsuji M, Amano T, Miyagawa K, Miyagishi H, Saito A, Imai T, Takeda K, Ishii D, Takeda H (2014) Neuroprotective effect of yokukansan against cytotoxicity induced by corticosterone on mouse hippocampal neurons. Phytomedicine 21:1458\u20131465","journal-title":"Phytomedicine"},{"key":"2400_CR30","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.neuroscience.2009.02.004","volume":"159","author":"Z Kawakami","year":"2009","unstructured":"Kawakami Z, Kanno H, Ueki T, Terawaki K, Tabuchi M, Ikarashi Y, Kase Y (2009) Neuroprotective effects of yokukansan, a traditional Japanese medicine, on glutamate-mediated excitotoxicity in cultured cells. Neuroscience 159:1397\u20131407","journal-title":"Neuroscience"},{"key":"2400_CR31","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0165-5728(98)00168-4","volume":"92","author":"M Hiremath","year":"1998","unstructured":"Hiremath M, Saito Y, Knapp G, Ting J, Suzuki K, Matsushima G (1998) Microglial\/macrophage accumulation during cuprizone-induced demyelination in C57BL\/6 mice. J Neuroimmunol 92:38\u201349","journal-title":"J Neuroimmunol"},{"key":"2400_CR32","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.4049\/jimmunol.1401459","volume":"194","author":"T Clarner","year":"2015","unstructured":"Clarner T, Janssen K, Nellessen L, Stangel M, Skripuletz T, Krauspe B, Hess FM, Denecke B, Beutner C, Linnartz-Gerlach B, Neumann H, Valli\u00e8res L, Amor S, Ohl K, Tenbrock K, Beyer C, Kipp M (2015) CXCL10 triggers early microglial activation in the cuprizone model. J Immunol 194:3400\u20133413","journal-title":"J Immunol"},{"key":"2400_CR33","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11064-006-9165-0","volume":"32","author":"LA Pasquini","year":"2007","unstructured":"Pasquini LA, Calatayud CA, Bertone U\u00f1a AL, Millet V, Pasquini JM, Soto EF (2007) The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia. Neurochem Res 32:279\u2013292","journal-title":"Neurochem Res"},{"key":"2400_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11064-013-1190-1","volume":"39","author":"S Morita","year":"2014","unstructured":"Morita S, Tatsumi K, Makinodan M, Okuda H, Kishimoto T, Wanaka A (2014) Geissoschizine methyl ether, an alkaloid from the uncaria hook, improves remyelination after cuprizone-induced demyelination in medial prefrontal cortex of adult mice. Neurochem Res 39:59\u201367","journal-title":"Neurochem Res"},{"key":"2400_CR35","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/1097-4547(20000801)61:3<251::AID-JNR3>3.0.CO;2-W","volume":"61","author":"JL Masson","year":"2000","unstructured":"Masson JL, Jones JJ, Taniike M, Morell O, Suzuki K, Matsushima GK (2000) Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination\/remyelination. J Neurosci Res 61:251\u2013262","journal-title":"J Neurosci Res"},{"key":"2400_CR36","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1742-2094-9-115","volume":"9","author":"B Stansley","year":"2012","unstructured":"Stansley B, Post J, Hensley K (2012) A comparative review of cell culture systems for the study of microglial biology in Alzheimer\u2019s disease. J Neuroinflammation 9:115","journal-title":"J Neuroinflammation"},{"key":"2400_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.14573\/altex.2009.2.83","volume":"26","author":"A Henn","year":"2009","unstructured":"Henn A, Lund S, Hedtj\u00e4rn M, Schrattenholz A, P\u00f6rzgen P, Leist M (2009) The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. ALTEX 26:83\u201394","journal-title":"ALTEX"},{"key":"2400_CR38","doi-asserted-by":"publisher","first-page":"15769","DOI":"10.1073\/pnas.95.26.15769","volume":"95","author":"J Yrj\u00e4nheikki","year":"1998","unstructured":"Yrj\u00e4nheikki J, Kein\u00e4nen R, Pellikka M, H\u00f6kfelt T, Koistinaho J (1998) Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci USA 95:15769\u201315774","journal-title":"Proc Natl Acad Sci USA"},{"key":"2400_CR39","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1007\/s11064-010-0202-7","volume":"35","author":"T Skripuletz","year":"2010","unstructured":"Skripuletz T, Miller E, Moharregh-Khiabani D, Blank A, Pul R, Gudi V, Trebst C, Stangel M (2010) Beneficial effects of minocycline on cuprizone induced cortical demyelination. Neurochem Res 35:1422\u20131433","journal-title":"Neurochem Res"},{"key":"2400_CR40","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1126\/science.3872478","volume":"228","author":"D Giulian","year":"1985","unstructured":"Giulian D, Lachman LB (1985) Interleukin-1 stimulation of astroglial proliferation after brain injury. Science 228:497\u2013499","journal-title":"Science"},{"key":"2400_CR41","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1523\/JNEUROSCI.08-07-02485.1988","volume":"8","author":"D Giulian","year":"1988","unstructured":"Giulian D, Woodward J, Young DG, Krebs JF, Lachman LB (1988) Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J Neurosci 8:2485\u20132490","journal-title":"J Neurosci"},{"key":"2400_CR42","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1084\/jem.164.2.594","volume":"164","author":"D Giulian","year":"1986","unstructured":"Giulian D, Baker TJ, Shih LC, Lachman LB (1986) Interleukin 1 of the central nervous system is produced by ameboid microglia. J Exp Med 164:594\u2013604","journal-title":"J Exp Med"},{"key":"2400_CR43","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s10571-011-9676-3","volume":"31","author":"S Imamura","year":"2011","unstructured":"Imamura S, Tabuchi M, Kushida H, Nishi A, Kanno H, Yamaguchi T, Sekiguchi K, Ikarashi Y, Kase Y (2011) The blood-brain barrier permeability of geissoschizine methyl ether in Uncaria hook, a galenical constituent of the traditional Japanese medicine yokukansan. Cell Mol Neurobiol 31:787\u2013793","journal-title":"Cell Mol Neurobiol"},{"key":"2400_CR44","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jep.2014.10.015","volume":"158","author":"K Mizoguchi","year":"2014","unstructured":"Mizoguchi K, Kushida H, Kanno H, Igarashi Y, Nishimura H, Ikarashi Y, Kase Y (2014) Specific binding and characteristics of geissoschizine methyl ether, an indole alkaloid of Uncaria Hook, in the rat brain. J Ethnopharmacol 158:264\u2013270","journal-title":"J Ethnopharmacol"},{"key":"2400_CR45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0304-3940(02)00218-5","volume":"325","author":"IO Han","year":"2002","unstructured":"Han IO, Kim KW, Ryu JH, Kim WK (2002) p38 mitogen-activated protein kinase mediates lipopolysaccharide, not interferon-gamma, -induced inducible nitric oxide synthase expression in mouse BV2 microglial cells. Neurosci Lett 325:9\u201312","journal-title":"Neurosci Lett"},{"key":"2400_CR46","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1084\/jem.20141656","volume":"212","author":"A Lampron","year":"2015","unstructured":"Lampron A, Larochelle A, Laflamme N, Pr\u00e9fontaine P, Plante MM, S\u00e1nchez MG, Yong VW, Stys PK, Tremblay M\u00c8, Rivest S (2015) Inefficient clearance of myelin debris by microglia impairs remyelinating processes. J Exp Med 212:481\u2013495","journal-title":"J Exp Med"},{"key":"2400_CR47","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/brain\/awn109","volume":"132","author":"H Neumann","year":"2009","unstructured":"Neumann H, Kotter MR, Franklin RJ (2009) Debris clearance by microglia: an essential link between degeneration and regeneration. Brain 132:288\u2013295","journal-title":"Brain"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-017-2400-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-017-2400-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-017-2400-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T13:41:02Z","timestamp":1589722862000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-017-2400-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,19]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2400"],"URL":"https:\/\/doi.org\/10.1007\/s11064-017-2400-z","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,19]]},"assertion":[{"value":"27 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}